Cardiovascular Assessment and Treatment During COPD Exacerbation to Improve Diagnosis and Outcomes

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

March 1, 2027

Study Completion Date

August 1, 2027

Conditions
COPD (Chronic Obstructive Pulmonary Disease)Cardiovascular Diseases
Interventions
OTHER

Cardiologist evaluation

The cardiology consultation will include the following: a structured interview (see Appendix A), physical examination, review of laboratory tests including HbA1c, lipid profile, BNP, ECG, and POCUS (point-of-care ultrasound) to assess heart contraction and valve function.

OTHER

Pulmonologist evaluation

optimize basic treatment, and recommend continued follow-up as needed.

Trial Locations (1)

Unknown

RECRUITING

Tel-Aviv Sourasky Medical Center, Tel Aviv

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Tel-Aviv Sourasky Medical Center

OTHER_GOV